Related Experiment Videos

High-dose intravenous immunoglobulin for post-transfusion purpura

T Becker, S Panzer, D Maas

British Journal of Haematology

|September 1, 1985

Abstract:

Five patients with post-transfusion purpura (four due to Zw(a), one presumably due to HLA antibodies) were treated with intravenous immunoglobulin (IgG) at doses of 0.4 g per kg body weight. IgG therapy was immediately effective as indicated by cessation of bleeding and rise of platelet counts in four out of five cases.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020

SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.

Cell death & disease·2013

[Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2009

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.

Bone marrow transplantation·2007

The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

The Journal of clinical endocrinology and metabolism·2001

Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation.

European journal of endocrinology·2001

See all related articles